Altered distribution and expression of protein tyrosine phosphatases in normal human skin as compared to squamous cell carcinomas

Journal of Cutaneous Pathology

Volumn 24, Issue 9, 1997, Pages 521-532

  Nanney, Lillian B ^a,b   Davidson, Mari K ^a   Gates, Ronald E ^a,b   Kano, Mio ^a   King Jr , Lloyd E ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL IMMORTALIZATION; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NORMAL HUMAN; SKIN; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL COMPARTMENTATION; CELL LINE, TRANSFORMED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINOCYTES; MICROTOMY; PARAFFIN EMBEDDING; PROTEIN-TYROSINE-PHOSPHATASE; SKIN NEOPLASMS; SRC HOMOLOGY DOMAINS; TUMOR CELLS, CULTURED;

EID: 0030708778     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb01456.x     Document Type: Article

References (50)

1. Tonks NK, Diltz CD, Fischer EH, Purification of the major tyrosine phosphatases of human placenta. J Biol Chem 1988: 263: 6722.
2. Charbonneau H, Tonks NK, Kumar S et al. Human placenta protein-tyrosine phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc Natl Acad Sci USA 1989: 85: 7182.
3. Walton KM, Dixon JE. Protein tyrosine phosphatases. Ann Rev Biochem 1993: 62: 101.
4. Stone RL, Dixon JE. Minireview: protein-tyrosine phosphatases. J Biol Chem 1994: 269: 31323.
5. Tonks NK. Protein tyrosine phosphatases and the control of cellular signaling responses. Adv Pharmacol 1996: 36: 91.
6. Sun H, Tonks NK. The coordinated action of protein tyrosine phosphatases and kinases in cell signaling. Trends Biochem Sci 1994: 19: 480.
7. Brady-Kalnay SM, Tonks NK. Protein tyrosine phosphatases as adhesion receptors. Curr Opin Cell Biol 1995: 7: 650.
8. Streuli M. Protein tyrosine phosphatases in signaling. Cur Opin Cell Biol 1996: 8: 182.
9. Mauro LJ, Dixon JE. 'Zip codes' direct intracellular protein tyrosine phosphatases to the correct cellular 'address'. Trends Biochem Sci 1994: 19: 151.
10. Frangioni JV, Beahm PH, Shifrin V, Jost CA, Neel BG. The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell 1992: 68: 545.
11. Mosinger B, Tillmann U, Westphal H, Tremblay ML. Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase. Proc Natl Acad Sci USA 1992: 89: 499.
12. Radha V, Kamatkar S, Swamp G. Binding of a protein-tyrosine phosphatase to DNA through its carboxy-terminal noncatalytic domain. Biochemistry 1993: 32: 2194.
13. Tillmann U, Wagner J, Boerboom D, Westphal H, Tremblay ML. Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase. Mol Cell Biol 1994: 14: 3030.
14. Neel BG. Structure and function of SH2-domain containing tyrosine phosphatases. Semin Cell Biol 1993: 4: 419.
15. Feng G-S, Pawson T. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet 1994: 10: 54.
16. Matozaki T, Kasuga M. Roles of protein-tyrosine phosphatases in growth factor signalling. Cell Signal 1996: 8: 13.
17. Rodrigues GA, Park M. Oncogenic activation of tyrosine kinases. Curr Opin Genet Dev 1994: 4: 15.
18. Saito S, Hashimoto N, Tokita K et al. Changes of expressions of phosphotyrosine phosphatases in rat hepatocellular carcinoma induced by 3-methyl-4-dimethylamino-azobenzene. Biochem Biophys Res Com 1996: 227: 406.
19. Partanen S. Histochemically demonstrable protein tyrosine phosphtase in human breast and colorectal cancer: large decrease in its activity in colorectal cancer suggests a tumor role in colorectal mucosal cells. Anticancer Res 1996: 16: 943.
20. Gunaratne P, Stoscheck C, Gates RE, Li L, Nanney LB, King LE, Jr. Protein tyrosyl phosphatase-1B is expressed by normal human epidermis, keratinocytes, and A-431 cells and dephosphorylates substrates of the epidermal growth factor receptor. J Invest Dermatol 1994: 103: 701.
21. Gates RE, Miller JL, King LE. Activity and molecular weight of protein tyrosine phosphatases in cell lysates determined by renaturation after gel electrophoresis. Anal Biochem 1996: 237: 208.
22. Gates RE, King Jr LE, Hanks SK, Nanney LB. Potential role for focal adhesion kinase in migrating and proliferating keratinocyges near epidermal wounds and in culture. Cell Growth Differ 1994: 5: 891.
23. Frangioni JV, Oda A, Smith M, Salzman EW, Neel BG. Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO J 1993: 12: 4843.
24. Rheinwald JG, Beckett MA.. Tumorigenic kerationcyte lines requiring anchorage and fibroblast support culture from human squamous cell carcinomas. Cancer Res 1981: 41: 1657.
25. Gates RE, Hanks SK, King LE. Focal adhesion components are enriched in ventral membranes isolated from transformed keratinocytes in culture. Biochem J 1993: 289: 221.
26. Kitadai Y, Bucana CD, Ellis LM, Anzai H, Tahara E, Fidler IJ. In situ mRNA hybridization technique for analysis of metastasis-related genes in human carcinoma cells. Am J Pathol 1995: 147: 1238.
27. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Can Res 1989: 49: 516.
28. Chen Y, Chen C-F, Riley DJ et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 1995: 270: 789.
29. Ottenhoff-Kalff AE, van Oirschot BA, Hennipman A, de Weger RA, Staal GE, Rijken G. Protein tyrosine phosphatase activity as a diagnostic parameter in breast cancer. Breast Can Res Treat 1995: 33: 245.
30. Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res 1992: 52: 478.
31. Woodford-Thomas TA, Rhodes JD, Dixon JE. Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J Cell Biol 1992: 117: 401.
32. Zander NF, Cool DE, Diltz CD, Rohrschneider LR, Krebs EG, Fischer EH. Suppression of v-fms-induced transformation of a truncated T-cell protein tyrosine phosphatase. Oncogene 1993: 8: 1175.
33. Klarlund JK. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell 1985: 41: 707.
34. LaForgia S, Morse B, Levy J et al. Receptor protein tyrosine phosphatase γ is a candidate tumor suppressor gene at human chromosome region 3 p21. Proc Natl Acad Sci USA 1991: 88: 5036.
35. Gaits F, Li RY, Ragab A, Selves J, Ragab-Thomas JM, Chap H. Implication of a protein-tyrosine-phosphatase in human lung cancer. Cell Mol Biol 1994: 40: 677.
36. Takekawa M, Itoh F, Hinoda Y et al. Chromosomal localization of the protein tyrosine phosphatase G1 gene and characterization of the aberrant transcripts in human colon cancer cells. FEBS Lett 1994: 339: 222.
37. c-src by overexpression of a protein tyrosine phosphatase. Nature 1992: 359: 336.
38. Mok SC, Kwok TT, Berkowitz RS, Barrett AJ, Tsue WL. Overexpression of the protein tyrosine phosphatase, non-receptor type 6 (TPTN6), in human epithelial ovarian cancer. Gynecol Oncol 1995: 57: 299.
39. Tahiti K, Smith DR, Goh H-S, Pallen CJ. Increased mRNA expression of the receptor-like protein tyrosine phosphatase α in late stage colon carcinomas. Cancer Lett 1995: 93: 239.
40. Galaktionov K, Lee AK, Eckstein J et al. CDC25 phosphatases as potential human oncogenes. Science 1995: 269: 1575.
41. Milarski KL, Saltiel AR. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 1994: 269: 21239.
42. Xiao S, Rose DW, Sasaoka T et al. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem 1994: 269: 21244.
43. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. Protein- tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci USA 1995: 92: 664.
44. Rivard N, McKenzie FR, Brondello J-M, Pouyssegur J. The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors. J Biol Chem 1995: 270: 11017.
45. Bignon JS, Siminovitch KA. Identification of PTP1C mutation as the genetic defect in motheaten and viable motheaten mice. Clin Immunol Immunopathol 1994: 73: 168.
46. Wiener JR, Hurteau JA, Kerns BJ, Whitaker RS, Conaway MR, Berchuck A, Bast RC. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am J Obstet Gynecol 1994: 170: 1177.
47. Wiener JR, Kerns BJ, Harvey EL et al. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with P185c-erbB-2 protein expression. J Natl Cancer Inst 1994: 86: 372.
48. Zhai Y-F, Beittenmiller H, Wang B et al. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 1993: 53: 2272.
49. Flint AJ, Tiganis T, Barford D, Tonks NK. Development of substrate-trapping mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 1997: 94: 1680.
50. Tomic S, Greiser U, Lammers R et al. Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. J Biol Chem 1995: 270: 21277.